Project leads
Collaborators

Post-Translational Modifications of Hsp90 that Impact Drug Efficacy

Leonard Neckers

3 Collaborator(s)

Funding source

National Cancer Institute (NIH)

Follow

Nicolas Winssinger

University of Strasbourg

Strasbourg, France

Matthias Mayer

Heidelberg University

Heidelberg, Germany

Laurence Pearl

University of Sussex

Brighton, United Kingdom

Leonard Neckers

National Cancer Institute (NIH)

Rockville, United States

Related projects

Nathanael Schiander Gray

Development and Application of Selective Covalent Cdk7 Inhibitors

All cancers but non-melanoma skin cancer

Sendurai A Mani

The Role of HMGA2 in Cancer; Epithelial-Mesenchymal Transition, Stem Cells and Cancer Progresion

All cancers but non-melanoma skin cancer

Laura D Attardi

Integrative approaches to elucidate p53 transcriptional networks during carcinogenesis

All cancers but non-melanoma skin cancer

Melissa Lajevic

Tumor-expressed wnts and dendritic cell tolerance in cancer immune evasion

All cancers but non-melanoma skin cancer

Mare Cudic

Novel Synthetic Tools for Mucin Glycobiology

All cancers but non-melanoma skin cancer

Patrick G Harran

Fully Synthetic Prodiginines as Probes of Protein-Protein Interactions Regulating

All cancers but non-melanoma skin cancer

Radiation Oncology

Ding Jin

Transcription Regulation in E. coli and H. pylori

All cancers but non-melanoma skin cancer

Ronald Wayne Davis

Revolutionizing Biomedical and Clinical Research through Innovative Technology

All cancers but non-melanoma skin cancer

Yves Pommier

DNA Repair, Cell Cycle Checkpoints and Apoptosis as Targets for Anticancer Drugs

All cancers but non-melanoma skin cancer